All For One Medi Financials

All For One Medi (AFOM) reported $9K in total revenue for fiscal year 2022. This represents a -5.3% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

All For One Medi (AFOM) revenue declined by 5.3% year-over-year, from $9K to $9K in fiscal year 2022.

All For One Medi (AFOM) reported diluted earnings per share of $0.00 for fiscal year 2022. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

All For One Medi (AFOM) had an operating margin of -5836.4% in fiscal year 2022, reflecting the profitability of core business operations before interest and taxes.

All For One Medi (AFOM) generated -$497K in operating cash flow during fiscal year 2022, representing cash generated from core business activities.

All For One Medi (AFOM) had $105K in total assets as of fiscal year 2022, including both current and long-term assets.

All For One Medi (AFOM) had 8.04B shares outstanding as of fiscal year 2022.

All For One Medi (AFOM) had a current ratio of 0.01 as of fiscal year 2022, which is below 1.0, which may suggest potential liquidity concerns.

All For One Medi (AFOM) had a debt-to-equity ratio of -1.01 as of fiscal year 2022, measuring the company's financial leverage by comparing total debt to shareholder equity.

Based on fiscal year 2022 data, All For One Medi (AFOM) had $99K in cash against an annual operating cash burn of $497K. This gives an estimated cash runway of approximately 2 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

All For One Medi (AFOM) has negative shareholder equity of -$15.3M as of fiscal year 2022, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

All For One Medi (AFOM) has a Piotroski F-Score of 2 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

All For One Medi (AFOM) scores 4 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.